Hoffmann-La Roche

Swiss healthcare company

1members1here now

Ask Genius Site

Hoffmann-La Roche· Health · 10 sources · Aug 24, 2026Story

FDA approves Alzheimer's blood test for age 40+

The FDA has cleared several Alzheimer’s blood tests, including PrecivityAD2 for adults 40 and older to aid diagnosis in symptomatic cognitive decline (not a general screening tool), and Elecsys pTau217 tests for those 55 and older to detect amyloid pathology and rule in or out Alzheimer's in various care settings, expanding access through Roche’s installed lab network and major providers. These tests, developed by Roche with Lilly and by other providers, aim to simplify early diagnosis and broaden eligibility for related treatments and care pathways.

Health· Aug 24, 2026

0

Hoffmann-La Roche· Health · 6 sources · Jul 24, 2026Story

Roche cobas BV/CV vaginitis test FDA-cleared

Roche has received FDA 510(k) clearance for the cobas BV/CV assay, which detects bacterial vaginosis and Candida vaginitis from a single vaginal swab using real-time PCR, promising more accurate diagnoses than traditional methods. The test can be run on the cobas platform alongside other sexual-health assays and is intended for professional laboratory use, aiming to reduce misdiagnosis and speed appropriate treatment.

Health· Jul 24, 2026

0

Hoffmann-La Roche

Swiss healthcare company

1members1here now

Ask Genius Site

Hoffmann-La Roche· Health · 10 sources · Aug 24, 2026Story

FDA approves Alzheimer's blood test for age 40+

The FDA has cleared several Alzheimer’s blood tests, including PrecivityAD2 for adults 40 and older to aid diagnosis in symptomatic cognitive decline (not a general screening tool), and Elecsys pTau217 tests for those 55 and older to detect amyloid pathology and rule in or out Alzheimer's in various care settings, expanding access through Roche’s installed lab network and major providers. These tests, developed by Roche with Lilly and by other providers, aim to simplify early diagnosis and broaden eligibility for related treatments and care pathways.

Health· Aug 24, 2026

0

Hoffmann-La Roche· Health · 6 sources · Jul 24, 2026Story

Roche cobas BV/CV vaginitis test FDA-cleared

Roche has received FDA 510(k) clearance for the cobas BV/CV assay, which detects bacterial vaginosis and Candida vaginitis from a single vaginal swab using real-time PCR, promising more accurate diagnoses than traditional methods. The test can be run on the cobas platform alongside other sexual-health assays and is intended for professional laboratory use, aiming to reduce misdiagnosis and speed appropriate treatment.

Health· Jul 24, 2026

0